A clinical study of minimally invasive left chest incision coronary artery bypass surgery

Longjin ZHU,Shuaizhou LIU,Tao ZHANG,Yunpeng LIN

DOI: https://doi.org/10.3969/j.issn.1009-6469.2017.01.028

2017-01-01

Abstract:Objective To summarize the clinical experience of the minimally invasive left chest incision coronary artery bypass surgery (MIDCAB),andtocompareitwiththeroutineoff-pumpcoronaryarterybypassgrafting(OPCAB).Methods Weselectedthequali-fied 21 cases of MIDCAB and chose optionally 30 cases of OPCAB,and then comparatively studied the basic conditions before the treat-ment and observedthe volume of drainage after the surgery,the mechanical ventilation time,ICU time,the hospital stayafter the surgery, the second opening stanching,the perioperative myocardial infraction and the death rate.And the follow-up visit continued for 3 ~24 monthsandweobservediftherewasanycaseofmyocardialinfarctionandanginapectorisornot.Results Therewasnodeathinthe group of MIDCAB,the mechanical ventilation time after surgery,ICU time,the volume of drainage after surgery,the input of the red cell volume,the cases of the pleural effusion,the cases of puncture and drainage,the cases of low cardiac output syndrome,the cases of IABP,the cases of renal insufficiency,the cases of the second opening stanching and the infection ratewere all lower than those of the OPCAB group;the follow-up visit indicated that LIMAB bridge was unobstructed and there wasno case of death due to myocardial infarc-tionoranginapectoris.Conclusions The minimally invasive left chest incision coronary artery bypass surgery(MIDCAB)is safe and reliable with little trauma,which can be applied to treat the pure anterior descending stenosis orthe stenosis complicated with the cir-cumflex artery and the moderate right coronary stenosis (TIMI Level III),or the cases in which the right coronary artery can be dealt by stent.MIDAB deserves popularization.